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Avainsanat: singlettihappi, väriaine, peryleeni diimidi, reaktiivinen happi, antimik-
robinen kemoterapia, valoherkistäjä 
Peryleeni johdannaisilla on monia käyttökohteita fotokemiallisissa prosesseissa. Niiden 
käyttöä on kuitenkin vähemmän tutkittu singlettihapen tuotannossa. Eräiden peryleeni-
diimidien on osoitettu olevan hyviä singlettihapen tuottajia. Singlettihapella on monia 
käyttökohteita. Tästä syystä näiden peryleenidiimidi johdannaisten tutkiminen olisi kan-
nattavaa.  
Uusi peryleeni diimidi molekyyli syntetisoitiin käyttäen peryleeni-3,4,9,10-tetrakar-
boksyyli dianhydridiä lähtöaineena. Synteesi käsitti 4 askelta. Jokaisen askeleen jälkeen 
tuote puhdistettiin ja analysoitiin. 
Analyysimenetelminä käytettiin NMR spektroskopiaa ja ESI-TOF massaspektrometriä. 
Lopullinen tuote analysoitiin lisäksi UV-Vis absorptio spetrometrillä. 
Näitä menetelmiä yhdistämällä saatiin todennettua uusi molekyyli. Tällä aineella on kes-
kinkertainen molaarinen vaimennuskerroin ja on järkevää seuraavaksi tutkia tämän ai-
neen antimikrobiset ominaisuudet. 
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ABSTRACT 
HEIKKI TIRKKONEN: Synthesis of novel perylene diimide dye, a candidate for 
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Perylene derivatives have many uses in various photochemical applications. Their use in 
singlet oxygen production has been less studied. Some perylene diimides have shown  
significant singlet oxygen yields. Singlet oxygen has many different uses. Therefore these 
perylene diimides are a lucrative field of study. 
A novel perylene diimide dye was synthesized using Perylene-3,4,9,10-tetracarboxylic 
dianhydride as starting material. Synthesis consisted of 4 steps. After each step the prod-
uct was purified and analyzed. 
Analysis methods were nuclear magnetic resonance spectroscopy and electrospray ioni-
zation time-of-flight mass spectrometry. Final product was additionally characterized 
with ultraviolet-visible light absorption spectroscopy. 
Combination of these studies enabled the verification of this novel molecule. Molecule 
presented moderate molar attenuation coefficient and it is viable to test the antimicrobial 
properties of this compound. 
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1. INTRODUCTION 
At the beginning of 21st century, one of the most crucial health care issues in the world is 
antibiotic resistance. While increasing number of pathogenic bacteria are developing re-
sistance against antibiotics, the amount of new antimicrobial drugs is decreasing every 
year. Antibiotics work by single mode or action and given enough time bacteria are able 
to develop sufficient countermeasures against them.  
A novel approach is to use excited oxygen molecules to inflict damage to microbes. These 
reactive oxygen species are naturally occurring in vivo and most of them are tolerated by 
cells to some extent. Singlet oxygen is the most reactive of these species and human path-
ogenic bacteria have no counter mechanisms against it. 
This approach is utilized in photodynamic antimicrobial chemotherapy. It is a treatment, 
which applies photosensitizers, a light source and oxygen from air. Unfortunately this 
type of treatment can only be applied topically, as tissue absorbs light very effectively. 
Suitable areas include: skin, lungs, nasal- and abdomen cavities.  
Similar approach could be applied to create antimicrobial surfaces. This could be 
achieved by surface coating, which would incorporate the photosensitizers. These sur-
faces could be applied wherever there is sufficient lighting. These antimicrobial surfaces 
could decrease the need of antibiotics altogether. 
Already several different types of photosensitizers have been developed. They are divided 
in to several groups according to their general molecular structure. They all have similar 
attributes, which include: decent absorption of visible light, good singlet oxygen yield 
and high molar attenuation coefficient. 
Perylene derivatives have been less explored as antimicrobial photosensitizers. However, 
they possess many desirable qualities and are therefore viable candidates for further in-
vestigation. 
In this work one novel perylene diimide derivate was synthesized. The structure of the 
molecule was verified by mass spectrometry and nuclear magnetic resonance spectros-
copy. 
Future studies include the verification of singlet oxygen quantum yield, dark toxicity and 
antibiotic properties of this novel molecule. Furthermore this molecule could be applied 
in tandem of suitable coating material to create antimicrobial surfaces. This molecule 
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could be used as basis of derivatives that could be applied as antimicrobial agents in pho-
todynamic antimicrobial chemotherapy. 
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2. LITERATURE REVIEW 
This review first takes a look at photodynamic antimicrobial chemotherapy. This is one 
of the main motivations behind this novel dye. The mechanism of action is the use of 
reactive oxygen species and singlet oxygen in particular. Singlet oxygen is also used in 
photodynamic therapy, which has the same principle of action that is used in photody-
namic antimicrobial chemotherapy applications. Common photosensitizer dyes are intro-
duced and finally the use of perylene derivatives as photosensitizers is explained. 
2.1 Introduction to photodynamic antimicrobial chemotherapy 
Dye therapy, without the use of photoactivation, has been used in the early 19th century 
to kill bacteria. One example is the use of methylene blue as a cure for malaria in 1891. 
After the discovery of penicillin, the research efforts switched from dyes to antibiotics 
derived from natural products, such as yeasts. However, they have an inherit problem: 
conventional antimicrobial drugs work with single mode or action. This enables microbes 
to develop resistances against them after sufficient exposure. [1] 
Some bacteria many form protective biofilm that is resistant to antibiotics and biocides. 
Biofilm protected bacteria need at least an order of magnitude higher concentration of 
these antibacterial agents in order to be killed as opposed to bacteria that are unprotected 
by biofilm. An example of biofilm in humans is dental plaque. [2] 
Nowadays several antibiotic resistant human pathogenic bacteria are known and effective 
means are needed as bacterial infections are once more becoming untreatable. In addition 
the number of new antibacterial agents approved for medicinal use is declining every 
year. One such approach is to apply photosensitizers in photodynamic antimicrobial 
chemotherapy (PACT). [3], [4] 
This is a form of antimicrobial therapy that utilizes the use of photosensitizer (PS), oxy-
gen and light. Currently PACT is used in skin pathogen decolonization, burn wound dis-
infection and treating oral cavity infections, such as root canal infection. [4]  
2.2 Reactive oxygen species 
PACT relies on in situ production of reactive oxygen species (ROS). These are usually 
created by radical reactions or by energizing molecular oxygen. ROS include: superoxide 
(O2
-), hydrogen peroxide (H2O2), hydroxyl radical (•OH) and singlet oxygen (1Δg O2). 
The first two are well tolerated in low levels by micro-organisms as they are produced in 
aerobic metabolism and respiration. Organisms are poorly capable to defend against hy-
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droxyl radicals and singlet oxygen and additionally large amounts of superoxide or hy-
drogen peroxide may defeat the defense mechanisms that micro-organisms have against 
these ROS. Singlet oxygen is considered to be the most effective ROS against living or-
ganisms. In addition human pathogenic bacteria seem to have no singlet oxygen quench-
ing strategies. This makes PACT a viable option as antimicrobial method and singlet ox-
ygen the most interesting of all ROS. In PACT singlet oxygen is generated by energy 
transfer from excited PS molecule to molecular oxygen. [5], [6] 
2.2.1 Excited state of molecular oxygen 
Oxygen is present in atmosphere and it is usually in molecular (O2) form that consists of 
two oxygen atoms. Atmosphere contains around 0.209 mole fractions of O2 at sea level. 
[7, p. 176] Oxygen atom has 8 electrons and their distribution in orbitals can be observed 
in Figure 1 below, which represents the electronic configurations of ground and excited 
state oxygen molecules. Electronic configurations follow Hund’s rule: “The lowest-en-
ergy configuration for an atom is the one having the maximum number of unpaired elec-
trons allowed by the Pauli principle in a particular set of degenerate orbitals.” [7, p. 562] 
Pauli’s principle states, that “An orbital can hold only two electrons, and they must have 
opposite spins.” [7, p. 556] Oxygen molecule has completely filled bonding 2pσ and 2pπ 
orbitals and it has two unpaired electrons in anti-bonding 2pπ orbital. 
 
Figure 1. Electronic configurations of triplet (left) and singlet (right) molecular oxygen. 
[8] 
Electrons have elemental quantum chemical property called spin. It has two possible val-
ues up or +½ and down -½. Nearly all organic molecules contain even number of elec-
trons. Additionally these electrons have equal number of up and down values. [9, p. 
14561] Spin states of molecules can be defined with the use of spin multiplicity: 
2𝑆 + 1,                (1) 
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Where S is the total spin quantum number. For these organic molecules the total spin 
number (S) gets the value of 0 and the multiplicity gets the value of 1. They are therefore 
said to have singlet state.  
Molecular oxygen on the other hand has two more electrons with one spin state than the 
other in its ground state. This is presented in left diagram in Figure 1 above. Furthermore 
because of these unpaired electrons, it has a permanent magnetic moment and it has total 
spin number of 1 in its ground state and the multiplicity gets value of 3. It is therefore 
said to have triplet ground state (3Σg). [10] Triplet ground state is the most stable and 
abundant form of oxygen, but it is possible to excite O2 to singlet excited state (
1Δg) with 
sufficient amount of energy. [8] 
Transformation from 3Σg to 1Δg state is spin-forbidden and because of this triplet ground 
state oxygen is relatively poor oxidizer for organic molecules under normal reaction con-
ditions. For example the reaction rates for oxidation reaction of linoleic acid are 1.3105 
M-1 S-1 and 8.9101 M-1 S-1 for 1Δg oxygen and 3Σg oxygen respectively. [8] 
2.2.2 Singlet oxygen production through photodynamic effect 
Oxygen molecule can be excited and it has two excited states with relatively low excita-
tion energies. These states are presented in Figure 2 below. The transition from first ex-
cited singlet state (1Δg) of O2 to the triplet state 3Σg is spin forbidden, therefore singlet 
excited state 1Δg is relatively long living. However, singlet oxygen is extremely reactive, 
which limits its effective radius in practical applications. This radius is dependent on the 
mean diffusion path length, which 1Δg can take before it gets in contact with reactant. 
Transition from second excited state (1Σg) is not spin forbidden and therefore this species 
is readily relaxed to 1Δg. Although the electronic configuration in the second excited state 
is similar to ground state, the last two electrons have antiparallel spins.  [11][12] 
 
Figure 2. Potential energy (kcal) per internuclear distance (Å) for molecular oxygen. 
[11] 
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There are several ways to produce singlet oxygen. These include enzymatic, chemical 
and photochemical routes. This thesis will concentrate on the photochemical route. This 
method involves photosensitizers that are molecules witch can absorb and transfer energy 
to oxygen molecule in order to excite it to singlet state. This process of excitation is de-
scribed with Jablonski diagram in Figure 3 below. [8] 
 
Figure 3. Jablonski diagram explanation on working of photosensitizers. [13, p. 4]  
Photosensitizers need to have: high absorption coefficient with the spectral region of used 
light, triplet state of the PS needs to have at least 94 kJ mol-1 of energy above ground state 
and to have a relatively long lifetime in order for them to work efficiently as photosensi-
tizers. The process of photoexcitation is described in Equation 2 below. [11] 
𝑃(𝑆0)
ℎ𝜈
→ 𝑃(𝑆1)
𝑘𝐼𝑆𝐶
→  𝑃(𝑇1)               (2) 
In the above equation P is photosensitizer, S0 is singlet ground state, S1 is first excited 
singlet state, T1 is first excited triplet state, hν is process of photoexcitation and kISC is the 
reaction rate of intersystem crossing.  
In the excitation process PS are excited with light that has suitable wavelength. This ex-
cites PS from ground state S0 to short lived lowest excited singlet state S1. Lifetime of this 
S1 state is in the nanosecond range. From here relaxation can happen through internal 
conversion, fluorescence and intersystem crossing (ISC). Singlet oxygen production hap-
pen via two photoprocesses that are indicated in Figure 3 as Type I and Type II. Therefore, 
the ISC is the most important pathway of S1 relaxation for photosensitizers. [13, p. 4] 
In internal conversion the excited state is relaxed via heat emission and in fluorescence 
the relaxation happens with the release of photon. Excited singlet state S1 can also relax 
to excited triplet state via intersystem crossing. Even though ISC is spin-forbidden path-
way a good PS will readily undergo this process. Because of the spin-forbidden nature of 
this reaction, the excited triplet state is relatively long lived. [8] 
Intersystem crossing reactions can happen via Type I or Type II pathways that are com-
petitive. In Type I pathway the excited PS will react directly with compound containing 
hydrogen (R-H). This reaction will happen either by donating or accepting hydrogen or 
7 
electron. This will form a radical that will react further. These radicals will produce com-
pounds such as hydrogen peroxide, anionic superoxide, hydroxyl radicals, nitric oxide 
and peroxide nitrite. In Type II pathway the PS will react with molecular oxygen O2 (
3Σg) 
and excite it to singlet state O2 (
1Δg). Singlet oxygen is one of the reactive oxygen species. 
This singlet oxygen can further react as electrophile. The rate of Type II pathway reaction 
depends mostly on the oxygen concentration and its solubility in the system as over 99 % 
of the reactions between triplet PS and triplet O2 form singlet oxygen. If the system runs 
out of oxygen the pathway may shift from Type II to Type I. [8][14] 
Singlet oxygen quantum yield (ΦΔ) is the efficacy of PS to produce singlet oxygen 
through Type II pathway of relaxation presented in Jablonski diagram above. This is a 
comparable number for different singlet oxygen producing photosensitizers that tells how 
efficiently the excitation of PS leads to singlet oxygen production. [15] 
ΦΔ of substance X is calculated using oxygen uptake experiment data and comparing this 
to a standard. 
ΦΔ
𝑋 = ΦΔ
𝑆𝑡𝑑 (
𝑅𝑂2
𝑋
𝑅𝑂2
𝑆𝑡𝑑) (
𝐼𝑆𝑡𝑑
𝐼𝑋
)                (3) 
Where ΦΔStd is the singlet oxygen quantum yield of the standard, RO2 is the initial rate of 
oxygen uptake and I is the integrated absorption spectrum over the transmission range of 
the filter that is used to normalize the number of photons absorbed by the sample and 
standard. [16] 
2.2.3 Applications for singlet oxygen and other ROS 
Singlet oxygen is notably more electrophilic than ground state oxygen, being ca. 1 V 
stronger oxidant. [11] It will react readily with unsaturated carbon-carbon (C-C) bonds, 
anions and neutral nucleophiles including sulfides and amines. Therefore, it can be uti-
lized in organic chemistry as synthetic reagent. [11], [17], [18] 
In synthesis singlet oxygen is generally reacted with olefin by 1,4-cycloaddition, “ene” 
reaction or 1,2-cycloaddition. These result in endoperoxide, allylic hydroperoxide and 
dioxetane respectively. The stereochemistry and the structure of the resulting molecule 
can be adjusted selecting different solvent and reaction systems. [17] 
Singlet oxygen has been utilized in photodynamic therapy (PDT). In PDT photosensitiz-
ers are excited with light that passes human tissue while still having enough energy to 
excite oxygen to singlet state. However, for efficient singlet oxygen production the energy 
of the PS triplet state should be somewhat higher than 94 kJ mol-1.  This limits the optimal 
wavelengths between 680 nm and 800 nm. Human tissue filters out shorter wavelengths 
and longer wavelengths do not have enough energy to efficiently excite singlet oxygen. 
Ideal photosensitizers would have these characteristics: availability, synthesizability, 
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high singlet oxygen quantum yield, strong absorption in 680-800 nm region with high 
attenuation coefficient, effective accumulation in tumor tissue and low dark toxicity for 
PS and its metabolites, Stable and soluble to tissue fluids and fast excretion from the body 
after treatment.[13, p. 34] Furthermore it should not be toxic without photo activation and 
it should have short enough half-life in patient to reduce the unwanted effects, such as 
light sensitivity. This mechanism of action is the same that is used in PACT. However, in 
PACT the targets are microbes instead of cancer cells. 
In PTD of cancer the photosensitizer is administered to patient. PS will then accumulate 
in the tumor during drug-light interval. Light is then administered directly to tumor using 
suitable wavelength. This can be achieved via regular lamp but usually fiber optics and 
laser is used. PS will produce the cytotoxic products from oxygen (Type I or Type II 
pathway) and these will destroy the tumor while leaving healthy tissue unharmed. [19] 
2.3 Applications of PACT   
Bacteria have multiple strategies to counter oxidative stress. Superoxide dismutase, pe-
roxidase and catalase are enzymes that neutralize the toxicity of ROS and protect bacteria 
from its environment. In addition in photosynthetic bacteria singlet oxygen can be 
quenched by triplet state of chlorophyll during photosynthesis or quencher molecules like 
carotenoid. [20] The main drawback in PACT compared to antibiotic is that PACT can 
currently only be applied topically. This limits the use of PACT to surface layers of dif-
ferent orifices and skin. This is due the fact that PACT requires photoactivation and the 
intensity of light will drastically decrease while travelling in tissue. [6] 
Most bacteria can be divided in to two groups using Gram staining. This test gives either 
positive or negative value depending on the chemical and physical properties of their cell 
walls. Gram (+) species have porous outer wall that allows PS with molecular weight up 
to 30000-60000 Da to cross, while Gram (-) species have outer membrane that prevents 
PS from entering bacteria unless their molecular weight is lower than 600-700 Da and PS 
is hydrophilic. Therefore Gram (-) bacteria are less sensitive to PACT. To circumvent this 
PS used in PACT should be cationic and hydrophilic so it can attach to Gram (-) bacteria 
outer wall. [6] 
So far the use of photoactivated dyes in antimicrobial treatment has been at experimental 
level and they are applied ancillary to conventional antimicrobial chemotherapy. Main 
issues in larger implementation of PACT instead of antibiotics are due to the clinical 
nature of the treatment, physical properties of the dye itself and the difficulty in admin-
istration. PACT treatment needs to be given in clinical environment as it includes drug 
administration, drug-light interval, illumination and removing of dye. Compared to anti-
biotic treatment, this is much more time consuming and cannot be done by patient at 
home. The dye itself is visible, coloring agent that will induce coloration on applied tis-
sue. This is a minor issue when decision is between coloration of skin and death of a 
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patient, but again when compared to non-coloring antibiotics PACT is less desirable. Cur-
rently PACT cannot be applied against large systemic infections such as septicemia. 
However, infections could be treated by PACT before they spread throughout the whole 
body. [1] 
Photosensitizers do not need to be in direct contact with bacteria for them to be effective. 
If PS is relatively close to bacteria the generated ROS can still have effect on nearby 
bacteria. This can be achieved by incorporating PS to surface that is in contact with bac-
teria. Compared to antimicrobial effect of PACT this method is far less efficient. How-
ever, this method allows continuous illumination of the PS and generation of ROS. There-
fore the antimicrobial effect becomes sufficient. [21] This opens up several possibilities 
to use the photodynamic effect against. Additionally this would allow full removal of PS 
from treated tissue when used in PACT. 
Another approach is to reduce the number of pathogens around us. One significant source 
of pathogens is contaminated environment. [22], [23] This issue could be addressed with 
antimicrobial surfaces. Pathogens could be disinfected on surfaces using photosensitizers, 
oxygen from air and light from common light bulbs. Additionally when PSs are used 
outside of human body the suitable absorption range is not restricted to 680 nm, but can 
include shorter wavelengths. By creating antimicrobial surfaces the need for antibiotics 
in general would decline. In addition to all surface materials used in hospitals, antimicro-
bial surfaces could be employed for example in mass transit systems and surface materials 
in public restrooms. The need for such surfaces is greatest in areas that are used by large 
masses or by already weakened individuals. [24] 
2.4 Immobilization of photosensitizers 
Photosensitizers could be implemented into surface materials either by encapsulating the 
dye molecules into the surface or by bonding the dye molecule to surface. However, this 
bonding should be strong enough to prevent leeching of dye out of the surface. Addition-
ally the PS needs to be in close proximity of the bacteria. 
Several different photosensitizers have been immobilized onto natural and synthetic pol-
ymers. These PS are introduced in the next chapter. Matrices for immobilization include: 
nanotubes and silica beads; synthetic polymers like polystyrene, polyurethane and nylon 
as well as natural polymers like chitosan, cellulose and cotton. Simplest method, where 
dye is dissolved, solution is applied directly on to surface and solvent is let to evaporate, 
would not sufficiently attach dye on to surface. Leeching of PS is a frequently encoun-
tered issue which can potentially lead to discharge of hazardous agents from the matrix. 
Therefore effective means of immobilization are required.  
One example of encapsulation is “swell-encapsulation-shrink” method. In this method 
crosslinked polymer is put in to appropriate solvent system that will allow the polymer to 
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swell. This will enable the dye and other small particles, such as nanoparticles, to enter 
the polymer matrix. After the solvent is removed by drying the polymer will shrink back 
to its original size. This could be used for silicone and polyurethane which are used in 
urinary catheter devices. This method was used to incorporate gold nanoparticles with 
phenothiazinium dyes (Methylene Blue and Toluidine Blue O) into aforementioned pol-
ymers. After illumination with 660 nm low power laser it was found that mechanical 
properties of these dyed polymers were not affected negatively. This material proved to 
be effective against both gram (-) and gram (+) bacteria with laser illumination. [24], [25] 
Dye molecules can be attached to polymer structure with ionic bonds. However, this could 
adversely affect the singlet oxygen quantum yields. This effect was presented in study by 
Inbaraj et al. [26] as they bonded cationic porphyrin derivatives onto functionalized pol-
ystyrene beads. 
Dye molecules can also be covalently bonded to surface. This is advantageous as the dye 
will come to closer contact with the bacteria, while still being strongly bonded to the 
surface. Phenothiazinium dyes were covalently bonded on to silicone rubber polymer. 
Despite the very small amount of dye present in silicone surface the samples demonstrated 
significant antimicrobial activity under illumination. [27] 
Another example of covalent bonding is nylon fiber which had protoporphyrin IX and 
zinc protoporphyrin IX covalently bonded to it using poly(acrylic acid) scaffold. This 
scaffold was used to increase the number of reactive sites on nylon-6,6 fibers for which 
the photosensitizer molecules could attach. This modified nylon-6,6 fiber showed antimi-
crobial properties against gram (+)  bacteria under illumination. Light intensity used in 
these tests was from 10 000-60 000 lux. This was partially above normal room light, 
which is around 30 000 lux. The zinc protoporphyrin IX version proved to be more effi-
cient in killing gram (+) bacteria. However the efficacy of bacteria killing was under 2 
log difference in colony forming units (CFU) throughout the test setup. [28], [29] 
Covalent bonding seems to be the best available option to prevent the leeching of dye 
molecules. This is the strongest bonding available for dye molecules. 
2.5 Traditional photosensitizer dyes 
Reactive oxygen species can be generated by several different photosensitizer molecules. 
These are molecules that absorb light in wavelengths that cover the visible light spectrum 
These molecules are often used in everyday life as colorants because of this ability to 
absorb and reflect visible light. These dyes can be divided to different groups by their 
core structures. 
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2.5.1 Porphyrins 
Porphyrin is the core for many derivatives that have been accepted as candidates for PDT. 
These include: Photofrin® (5) (hematoporphyrin derivative), Levulan® (5-aminolevulinic 
acid, 14), Metvix® (methyl aminolevulinate) and Visudyne® (verteporfin). In this list Le-
vulan® and Metvix® are prodrugs that transform into porphyrin derivatives via enzyme 
activity. These are presented more in depth later. [30] 
Porphyrin derivatives absorb light at long wavelengths very efficiently. This increases 
their efficacy in PDT. Extinction at longer wavelengths is stronger with chlorin and bac-
teriochlorin. In addition, coordinated metal in the center of molecule can blue shift the 
furthest red absorption band and it strengthens the most bacteriochlorin bands. [31] 
The porphyrin, chlorin and bacteriochlorin molecules are presented in Figure 4 below. 
Chlorin has a double bond in pyrrole ring B reduced (positions 7,8). Bacteriochlorin has 
two bonds reduced in rings B and D (positions 7,8 and 17,18 respectively). These differ-
ences have been emphasized using circles in below Figure 4. [19]  
NH
NNH
NNH
NNH
N NH
NNH
N
(1) (2) (3)
 
Figure 4. Molecules of porphyrin (1), chlorin (2) and bacteriochlorin (3) respectably. 
Difference between the molecules has been emphasized using circles. 
The first United States Food and Drug administration approved PDT sensitizer for cancer 
treatment belonged to porphyrin family, being a hematoporphyrin derivate (HpD). It was 
porfimer sodium that was sold under the brand name Photofrin®(5). Porphyrin family also 
includes hemoglobins that are porphyrin derivates containing iron. One example, Heme 
B, can be seen in Figure 5 below. Hematoporphyrin, the first candidate for PDT, was first 
produced by removing the iron from blood pigment hemin.[19] 
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Figure 5. Molecule of Heme B (4). 
Photofrin® belongs to first generation of photosensitizers. They are a group of PS that 
have mixture of different mono-, di- and oligomeric porphyrin structures and their molar 
attenuation coefficient (εmax) is relatively low. For Photofrin® the wavelength for maxi-
mum absorption (λmax) is at 630 nm with εmax value around 3000 M-1 cm-1. [19] This wave-
length is not optimal, as tissue penetration at 630 nm is around 2-3 mm. Furthermore 
Photofrin® accumulates in tissue and results in photosensitivity for 6 to 10 weeks. On the 
positive side its singlet oxygen quantum yield is high, ΦΔ=0.89. Photofrin® has been ap-
proved for PDT treatment of several different types of cancer that affect some tissue sur-
face. These include endobroncheal, cervical, lung and bladder cancers. [19] 
NH N
NHN
CH3
O
CH3 CH3
R
CH3
CO
CH3
CO2Na
n
(5)
 
Figure 6. Structure of Photofrin (5), where n=0..6 
Second generation of photosensitizers were more potent in PDT than HpD, but still pre-
sented significant undesirable photosensitivity after treatment. One example of these is 
meta-tetra(hydroxyphenyl)porphyrin (m-THPP) as seen in Figure 7 below.[19] This con-
stitutes of porphyrin skeleton that has 4 meta-hydroxyphenyl substituents attached to it. 
Substance m-THPP has λmax value of 644 and εmax value of 3400 with ΦΔ being 0.61 in 
air saturated solution. [32], [33] 
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Figure 7. Example of second generation photosensitizers, m-THPP (6). 
Several candidates for PDT are derived from chlorin family. Chlorin based PDT drugs 
include: Foscan® (Temoporfin), Laserphyrin® (Talaporfin) and Photochlor® (HPPH). 
[30] Chlorins differ structurally from porphyrins only by having the C pyrrole ring re-
duced at 17,18-positions. Molecule in Figure 8 below is meta-tetra(hydroxyphenyl)chlo-
rin, (m-THPC, 7). The difference between chlorin and porphyrin is emphasized with red 
circle in structure on m-THPC. This small difference in structure shifts absorption band 
from 640 nm to 700 nm. m-THPC is sold under brand name Foscan® and it has εmax of 
29600 M-1 cm-1 at 650 nm. [19] 
 
OH
OH
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NH N
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Figure 8. Example of chlorin based PDT candidate, m-THPC (7). 
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2.5.2 Phthalocyanines 
Phthalocyanines (Pc) have analogous structure to porphyrins adding 4 benzene rings 
fused to pyrrole units and 4 nitrogen connecting those pyrrole rings instead of methyne 
bridges.  
Pcs have generally high efficacy for ROS production, low dark toxicity and reach chem-
istry of chemical modification. Additionally, introducing coordinating diamagnetic metal 
atom into the inner cavity of the Pc ring has proven to increase triplet quantum yield and 
lifetime and produce high amount of singlet oxygen. These metals include Zn, Si, Al, Ga 
and In. [34] 
Symmetrically substituted Pcs have been utilized for PDT. However, decreasing the sym-
metry of substitution increases singlet oxygen yield. [34] 
One example is aluminum phthalocyanine tetrasulfonate (AlPcS4) that is sold under 
brand name Photosens®. It has λmax value of 676 and εmax of 200000 M-1 cm-1 with ΦΔ 
being 0.38. It has been approved for use in Russia for PDT treatment of several types of 
cancers including skin, oral and breast cancers. However, Photosens® produces photosen-
sitivity for skin for several weeks. [19] 
Cl
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Figure 9. Structure of AlPcS4 (8). 
2.5.3 Phenothiazines 
Phenothiazines are a group of dyes that are based on the structure presented in Figure 10 
below. They have been used as antimicrobial agents before the development of penicillin 
and sulfonamides. Because of their widespread use and large amount of accumulated re-
search data they were amongst the first dyes to be utilized in PDT. Methylene blue is 
currently approved for photodynamic inactivation of blood plasma and blood platelets. 
[35] 
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Figure 10. General structure of phenothiazine dye (9). 
Methylene blue (MB) is one of the phenothiazinium family sensitizers. It has λmax at 666 
nm and εmax 82000 M-1 cm-1. Another example is Toluidine blue O (TBO) that has λmax at 
596 nm and 630 nm and εmax(630 nm) 51000 M-1 cm-1. Their advantages include low dark 
toxicity, cationic charge and their photophysical and -chemical properties well suited for 
PDT. [19] 
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Figure 11. Structures of Methylene blue (MB, 10) and Toluidine blue O (TBO, 11) 
respectively. 
Both molecules are well known and studied photosensitizers. They have been shown to 
be effective against a multitude of microorganisms. [36] These molecules have been de-
veloped further increasing their cationic nature by additional tertiary ammonium moie-
ties. One example is methylene blue derivate in Figure 12 below. The additional cationic 
charge on the other side of the core group increased antimicrobial photodynamic effect 
when compared to MB. [37] 
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Figure 12. Structure of 3,7-di(piperazin-4-ium-1-yl)-3,9a-dihydrophenothiazin-5-ium 
trichloride (12). 
2.5.4 Curcumin 
Curcumin is one of phytochemicals found in rhizome of Curcuma Longa which is also 
known as turmeric, a common coloring and flavoring agent. This rhizome has tradition-
ally been used as insect repellant and antimicrobial agent. Curcumin is well tolerated even 
in high doses of 12 g/day and it has antimicrobial, antiviral and antifungal properties. 
Curcumin has been extensively studied and it has been tested as antimicrobial dye for 
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cotton and wool. It has been used as one of active ingredients in antimicrobial skin emul-
sion. Curcumin has proven dark antibacterial properties and curcumin extract that were 
prepared from turmeric using different solvents proved to be effective in relatively low 
concentrations. Most efficient solvent was found to be ethanol that had minimum inhibi-
tory concentration of 3.91-125 ppt against 24 different pathogenic bacteria that were iso-
lated from chicken and shrimp. In addition curcumin displayed biofilm inhibiting abili-
ties. However, poor solubility to aqueous solvents and inadequate bioavailability limit the 
use of curcumin as antimicrobial agent. [38] 
Curcumin has λmax at 420 nm and εmax 55000 M-1 cm-1. It has been proposed as a PDT 
substance for destroying bacteria. [19] 
OHO
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Figure 13. Structure of Curcumin (13) in enol form. 
2.6 Other photosensitizers 
5-Amino-4-oxopentanoic acid (5ALA) will enzymatically transform to Protoporphyrin 
IX (PpIX) via heme pathway when ALA prodrug is applied to skin. ALA derivatives have 
been proposed as drugs for cancer diagnosis in cancers affecting skin and different body 
cavities such as lungs, bladder and gastrointestinal tract. 
 5ALA is currently approved for treatment of actinic keratosis under brand name Levulan 
Kerasticks®. It has λmax at 632 nm and εmax 5000 M-1 cm-1 with ΦΔ being 0.56. [19] 
O
NH2O
OH
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Figure 14. Structure of 5-amino-4-oxopentanoic acid (5ALA) (14). 
Rose Bengal (RB) is anionic, water soluble photosensitizer with high singlet oxygen yield 
with exceptional effectiveness against gram (+) bacteria. [22] Polycathionic chitosan-
conjugated RB was tested against gram (-) P. aeruginosa and it was found to be more 
effective than RB alone. [39] 
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Figure 15. Structure of Rose Bengal (15).  
Ruthenium (II) metal complexes, such as 1,10-phenanthroline-5,6-dione (phendione) and 
2,2’-bipyridine (bpy) have presented photoactivated microbial killing effect. They have 
cationic structure, are water soluble and are biologically compatible. [40], [41] 
2.7 Perylene derivatives as photosensitizers 
Perylene diimides (PDI) derivatives have been utilized in large variety of applications 
due to their high thermal- and photo stability against visible light, high chemical stability 
and easily tuneable absorption attributes, high molar absorption coefficient and fluores-
cence quantum yield, nontoxicity and low cost. [10], [42] Applications for PDI deriva-
tives include dye lasers, organic light emitting diodes, dye sensitized solar cells, organic 
field effect transistors and liquid crystal displays. [43] 
Using different substituents in PDI, one can cover the entire visible light spectrum with 
their absorption spectra. [44] In addition to aforementioned applications PDI derivatives 
are currently used in G-quadruplex stabilization and telomerase inhibition in cancer cells. 
[45], [46] 
Telomerase is responsible of growth of the cancer cells. It adds DNA back to telomeres 
thus accelerating the uncontrolled growth of tumor. G-quadruplex formation obstructs 
telomerase elongation in vitro. [47] In PDT the PS needs to be selective and accumulate 
to cancerous cells instead of healthy cells. This could be achieved using G-quadruplex as 
carrier for the PS. This makes PDIs intriguing candidate for basis of PDT agent. [48]  
However, so far no perylene diimide based drugs have been proposed for PDT. Unsub-
stituted perylene diimides are poor photosensitizers as their intersystem crossing quantum 
yield is approximately ΦISC = 0.005. [49] However, appropriate substituents can change 
this drastically. One example is perylene diimides derivate, N-(2,6-diisopropylphenyl)-
N′-(3-carboxy-2-pyridyl)- 1,7-bis{4-[(4-pyrene-1-ylbutanoyl)oxy]phenoxy}perylene-
3,4,9,10 -tetracarboxylic diimide (PDI-Pyr, 16) which has shown singlet oxygen quantum 
yield of ΦΔ = 0.93. [47] 
In addition PDI-Pyr and N-(2,6- diisopropylphenyl)-N′-(3-carboxy-2-pyridyl)-1,7-bis{4-
[(4-in- dole-3-ylbutanoyl)oxy]phenoxy}perylene-3,4,9,10- tetracarboxylic diimide (PDI-
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In, 17) both showed DNA binding affinity from their side chains. This was due to their 
nitrogen and oxygen groups in their cationic forms. In addition the G-quadruplex binding 
could be applied to deliver the PDI-Pyr to cancer cells. [47] 
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Figure 16. Structures of PDI-Pyr and PDI-In. Both of these unsymmetrical PDIs present 
promising singlet oxygen quantum yields. 
 
Possibility to adjust absorption, high singlet oxygen quantum yield and the ability to tar-
get cancer cells make PDIs an interesting and promising candidate for PDT. Similar at-
tributes are needed in PACT applications. 
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3. RESULTS AND DISCUSSION 
Some perylene diimide derivatives show promising features for ROS generators and a 
study conducted by Dinçalp et al. reported these examples. [47] More study is still re-
quired in this field as only a few such examples exist. 
Purpose of this thesis was to synthesize new molecules that could be later tested for their 
ability to generate ROS. Synthetic plan consisted of three lines that all shared the same 
first two synthetic steps. The schemes are presented in APPENDIX A. 
Perylene-3,4,9,10-tetracarboxylic dianhydride (PTCDA) consists of 2 carboxylic anhy-
dride groups that are at peri-positions of perylene molecule. These parts are marked with 
blue and red color circles in Figure 17 below.  
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Figure 17. Structure of PTCDA (18) molecule. On the left side its carbons are numbered 
and on the right side its different functional parts are emphasized with colored circles. 
PTCDA is insoluble in organic solvents.  This is due to the extensive face-to-face π-π 
stacking of these molecules. [50] However, it can be dissolved in concentrated sulfuric 
acid. This is true for nearly all perylene pigments and it happens via protonation. [51] 
The aromatic carbons in the perylene core form a characteristic cavity, so called “bay 
area”. It corresponds to the positions 1,6,7,12 of PTCDA. Later “1,6- and 1,7- isomers” 
will refer to substitution in these bay-area positions. 
3.1 Original plans for synthesis 
Synthetic scheme consisted of three plans. All of the plans started with same two steps. 
These steps are given in the Figure 18 below. 
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Figure 18. The two first synthetic steps. The dibromo PDI (20) was common starting 
material for all consecutive synthetic schemes. 
First target molecule was quaternary salt of 1-pyrrolidine,7-carbazole PDI. First two syn-
thetic steps were conducted without any difficulties. However, the third step proved very 
problematic. Last three steps of the first plan can observed in the Figure 19 below. These 
attempts are disclosed in greater detail in chapter 3.3 
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Figure 19. The last three steps of the first synthetic plan. 
Second target molecule was quaternary salt of disulfonyl-4-pyridine PDI. This synthesis 
was performed up to the second to last step without any insurmountable difficulties. How-
ever, after the sulfonating step the product was found to be water soluble. This was sur-
prising and because of limited time this could not be purified. Therefore thiol-4-pyridine 
PDI was quaternized to produce cationic dye. 
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Figure 20. Last three synthetic steps of the second synthetic plan. 
Third target molecule was quaternary salt of  PDI with 1,7-bis(4-hydroxyphenyl 3-(pyren-
1-yl)propanoate) (HPP-PDI) substituents. Here again the third synthetic step, hydroqui-
none substitution, proved difficult. This was due to possible polymerization of the PDI 
units as the hydroquinone could react with both ends. Product could not be purified with 
CC as it would not pass the column. To circumvent this issue, hydroquinone was at-
tempted to mono-protect in order for it to react with only one end. This proved to be too 
challenging. Therefore this plan was abandoned. Third plan can be observed in below 
Figures 21 and 22. 
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Figure 21. The 3rd and 4th step of third synthetic plan. 
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Figure 22. The 5th step of third synthetic plan. 
3.2 Accomplished synthesis 
This chapter describes in detail the synthetic scheme to produce Qt-salt of dimercapto-
pyridine PDI.  
3.2.1 Synthesis of dibromo PTCDA 
Reaction scheme started with introduction of bromine atoms to bay area of PTCDA to 
produce compound 19. Target was 1,7-dibromo perylene-3,4,9,10-tetracarboxylic di-
anhydride (dibromo PTCDA). Bromine is needed in order to introduce functional groups 
to bay area positions later. This also increased the solubility of compound to organic sol-
vents by bending the core structure and adding large substitute atoms to bay area posi-
tions. This decreased the face-to-face π-π stacking of these molecules. [52] This made 
PTCDAs soluble to chloroform. [50] 
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Figure 23. Synthesis of dibromo PTCDA (19) using PTCDA (18) as starting material. 
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In the first step starting material was dissolved in concentrated H2SO4. This was done by 
stirring the solution for 24 hours (h) in room temperature (RT). The red solid seemed to 
have dissolved completely in the acid. In the next step iodine was added in to solution of 
PTCDA. Iodine was added before bromine in order for it to react with PTCDA. Iodine 
acted as catalyst for subsequent bromination. Bromine evaporated strongly during addi-
tion giving out brown toxic and caustic fumes. Because of this strong activity, bromine 
was added all at once. This addition were done under fume hood. After adding iodine and 
bromine heating was started. Reaction was kept at 90 °C for 24 h. 
After heating was removed and vial had cooled to RT, the cap was opened. There were 
visible brown colored fumes released from the vial. Vial was placed tilted near the exhaust 
of the fume hood and left there for one hour. 
A total of 2.0 ml of water was added to reaction vial to precipitate the product out. Some 
product however remained in solution. This was very exothermic reaction and therefore 
vial was placed in to water bath to cool it down. Added a bit more water and then trans-
ferred product in to №4 filter using water. (See Table 3 for pore size) 
A total of 12 ml of 80 % H2SO4 was prepared using concentrated H2SO4 and water. This 
was performed using 10 ml of H2SO4 to which 2 ml water was added dropwise. This 
prepared 80 % H2SO4 solution was used to wash the product (19). Filtrate had strong red 
coloring and it was once more filtered. 
Second filtering is more promising as filtrate is now clear. Water is used to wash product 
and precipitate is agitated with spatula during washing. Washing is continued until pH of 
waste water is around the same as the used washing water. 
Product was dried on filter using suction and after that it was placed in to vacuum desic-
cator. At this point product was not purified as the isolation of 1,7- and 1,6- isomers is 
not possible using column chromatography because of poor solubility. [53] 
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3.2.2 Synthesis of dibromo PDI 
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Figure 24. Synthesis of dibromo PDI (20) from dibrominated PTCDA (19). 
Imidation of dibromo PTCDA was done using dry dibromo PTCDA as starting material. 
In this synthesis the anhydride cycles of the molecule react with the amine creating di-
bromo-perylene diimide (dibormo PDI). This particular amine was selected because it 
can be quaternized later, making the molecule water soluble. 
Synthesis was performed under argon gas (Ar). Starting material was added in to vial with 
a stirring bead. Vial was closed with a cap that had 3 small holes on top of it. Gentle Ar-
flow was applied through the cap with 2 needles connected to silicon hose. Flow of Ar 
was controlled with bubbling it through oil. Solvents were added with syringes and nee-
dles through the 3rd hole in the cap. After this stirring was started. Last the N,N-di-
methylethane-1,2-diamine (DMEN) was added with syringe and needle through the 3rd 
hole. After this heating was started and when temperature had reached around 70 °C the 
Ar flow was stopped and cap sealed with parafilm. Heating was continued until reaction 
temperature was reached. Reaction was kept at 85 °C for 2 hours and after that heating 
was removed. During this time the color changed from bright red to dark red/violet. The 
color can be observed in Figure 25 below.  
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Figure 25. Vial containing component 19 after cooling back to RT. 
 
After vial had returned to RT water was added to precipitate the product and stop the 
reaction. The precipitate was filtered off on №4 filter and washed with water several times 
with applied suction. Filtering proved extremely difficult and excess solvents were re-
moved with rotary evaporator. 
Precipitate was dried in vacuum desiccator and dissolved in minimum amount of chloro-
form. Product was purified using column chromatography (CC). The product had strong 
red color wich can be seen in the Figure 26 below. Column was prepared using 50 ml of 
silica 100. Column was packed using pure CHCl3 and silica. At the beginning pure CHCl3 
was used to drive the product. Gradually the polarity of the eluent was increased until the 
final composition of eluent was CHCl3:EtOH:Et3N (93:6.5:0.5). One major fraction was 
collected and it was found to contain mixture of 1,7- and 1,6- isomers of dibromo PDI 
20, as proved by high-resolution mass spectrometer (HRMS) and nuclear magnetic reso-
nance (NMR). However, this isomeric mixture was deemed pure enough for subsequent 
synthetic steps and possibility of isomeric purification with CC was higher with larger 
bay-area substitutes. [54] 
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Figure 26. Column chromatograph setup used in purification of dibromo PDI (20). 
 
HRMS results can be observed in APPENDIX B. Below in Figure 27 is the NMR spec-
trum of dibromo PDI. 
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Figure 27. 1H NMR spectrum of dibromo PDI (20) in CDCl3. 
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Aromatic region in the 1H NMR spectrum of dibromo PDI shows signals that are multi-
plets instead of clear doublets. This can be observed for signals at chemical shift 9.24 
ppm (J=8.19 Hz) and 8.50 ppm (J=8.19 Hz). Singlet at 8.70 ppm which corresponds to 
the protons connected to carbons 2 and 8 is not repeated in any other location.  It might 
have different value for 1,6-isomer, but whether this is the case remains unknown. The 
triplet located at 4.31 ppm corresponds to CH2 that are next to the imide nitrogen and 
triplet at 2.66 ppm corresponds to the other CH2 group in the imide tails. Singlet at 2.34 
corresponds to the 12 protons that are in the 4 methyl groups which are connected to the 
amines. 
MS (ESI-TOF) [M+H] signals: found 691.0353, calculated 691.0381, lock mass 
556.2771, Accuracy 3.0 ppm. These results, in conjunction with the above NMR test re-
sults, confirm the presumed structure of target molecule. 
3.2.3 Synthesis of dimercaptopyridine PDI 
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Figure 28. Synthesis of dimercaptopyridine PDI (30). 
Dibromo PDI was used as starting material for synthesis of dimercaptopyridine PDI. Dry 
potassium carbonate acted as base it the reaction. Reaction was performed at low temper-
ature following procedure from literature. [44] This was achieved using insulated ice bath 
with ice/NaCl mixture that is shown in the Figure 29 below.  
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Figure 29. The setup for chilled reaction. 
Ice and salt were mixed in a plastic bowl before adding this mixture to insulated vessel. 
This guaranteed sufficient mixing of salt and ice and led to below freezing temperature 
of this cooling bath. Reaction time was around 3 hours and despite of all the insulation 
the ice slowly melted. This was countered by removing water and adding ice/NaCl mix-
ture to the ice bath approximately twice per hour. TLC was preformed to in order to define 
the progress of the reaction and reaction deemed complete after 3 hours. Water was added 
to vial to precipitate the product. Mixture was filtered on №4 filter and it was left there to 
pass though the filter overnight. Filtrate was strongly colored and NaCl was added to 
filtrate to precipitate the product out. This helped and the next filtering was successful. 
Column was prepared using 30 ml of silica 100 and using CHCl3:EtOH:Et3N (93:6.5:0.5) 
as eluent. However, this did not produce desired separation as can be seen in Figure 30 
below. In Figure 30 several different components can be observed and they are numbered 
in the upper plate. Search for suitable stationary phase/eluent-combination produced alu-
mina/ CHCl3:EtOH (100:1) as best option. 
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Figure 30. TLC plates used to determine suitable stationary phase/eluent combination. 
TLC was developed using starting material, co-spot and product, which had been CC 
purified before. 
Because the amount of product was small enough, the purification was done using TLC 
on alumina plates. This method produced relatively good separation of components. 
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Figure 31. 1H NMR spectrum of dimercaptopyridine PDI (30) in CDCl3. 
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NMR experiments were conducted using CDCl3 as solvent. This solvent contains trime-
thylsilane (TMS) as internal standard. The 1H NMR spectrum was corrected using values 
7.27 ppm for CDCl3 and 0.00 ppm for TMS. From the spectrum it is evident that this 
substance is not pure 1,7-isomer. 
Signals with chemical shift 2.33-2.39 ppm correspond to methyl groups connected to 
amine tails at the peri-positions. This signal was expected to be singlet, but due to shim-
ming issues signal is not completely clear. Additionally some aliphatic impurities are pre-
sent and these produce signal with chemical shift of 1.25 ppm. Two triplets at 2.70 ppm 
and 4.34 ppm correspond to the CH2 groups of these peri-position imide tails. The shifts 
are close to what was observed in starting material.  
Aromatic part is problematic as it would be expected that the protons connected to the 
perylene core would have different chemical shifts from each other. If this were true, it 
would create: 2 doublet signals with differing chemical shifts and integral values of 4, 2 
singlet signals with integral value of 2 and 2 doublet signals with integral value of 2. 
These 2 doublet signals would correspond to the CH groups located in pyridine moieties, 
2 singlet signals would correspond to the CH groups located in perylene core numbered 
2 and 8 and 2 doublet signals would correspond to the CH groups located in perylene core 
numbered 5, 6, 11 and 12. 
Aromatic part is unclear because of presence of both 1,6- and 1,7-isomers and due to 
shimming issues.  
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3.2.4 Synthesis of quaternary (Qt-) salt of dimercaptopyridine 
PDI 
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Figure 32. Quaternarization of dimercaptopyridine PDI (31). 
Quaternarization was conducted using large excess (~600 eq) of methyl iodide (MeI). The 
progress of this reaction was followed by TLC but this proved difficult. There was no 
way to tell if all quaternizable nitrogen atoms had reacted. Reaction was stopped after 18 
hours and product was precipitated using diethyl ether. Ether was used to wash product 
several times on watch glass to remove any remaining MeI and MeCN. 
After drying the product, MS was used to determine the mass to charge ratio of product. 
The mass to charge ratio from MS (ESI-TOF) measurements proved that some molecules 
had not completely quaternized. Therefore quaternarization was performed again to this 
product to ensure full quaternarization. 
This time the reaction was conducted using N,N-Dimethylformamide (DMF) as solvent. 
Again large excess (~300 eq) of MeI was used. Reaction was conducted in RT and it was 
stirred for around 16 hours. After this the same ether precipitation and washing was con-
ducted to remove unreacted materials and excess solvents. HRMS was used to determine 
that quaternarization had completed. 
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3.2.5 Verification of the structure of the target molecule 
This molecule was verified using MS (ESI-TOF) and NMR. Mass spectrum was inter-
preted by first checking the number of charges for every signal obtained. This can be 
calculated from the distance between peaks in isotopic patterns. ESI-TOS gives mass to 
charge ratio (z/m) signals from substance. Therefore substance, like our Qt-salt of dimer-
captopyridine PDI, that has 4 charges will have 0.25 Dalton (Da) difference between sig-
nal maximums. However it became evident that this salt was not completely ionized and 
instead charge numbers 2 and 3 were observed with masses corresponding additional io-
dine atoms. 
UV-Vis spectrum showed absorption maximum λmax at 530 nm with molar attenuation 
coefficient ε of 24344 (M-1cm-1). Measurements were conducted in water. 
 
 
NMR spectrum was adjusted with D2O solvent peak at 4.75. Signal observed at 2.68 ppm 
was believed to correspond to trace amounts of DMF. [55] 
Spectra  that were measured: 1H, 13C, COSY (COrrelation SpetcroscopY), gHSQC (gra-
dient Heteronuclear Single Quantum Correlation) and gHMBC (gradient Heteronuclear, 
Multiple Quantum Correlation).  
From these signals gHSQC and gHMBC had poor signal to noise ratio in aromatic region. 
Therefore some proton and carbon signals were not able to be paired definitively. 
COSY gives signals of coupled protons. It shows proton signals that are at neighboring 
carbons away from each other and thus gives information on structure on the molecule. 
This is called scalar coupling by the way, J-coupling 
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HSQC gives signal that correlate chemical shifts of proton connected to other nucleus via 
J-coupling. From gHSQC spectrum it is possible to determine type of carbon-proton sys-
tem, as positive signals correspond to CH and CH3 systems and negative signals corre-
spond to CH2 and CH4 systems. These values are presented with (+) and (-) respectively. 
HMBC assigns 1H and 13C signals based on long-range J-coupling. From this spectrum it 
is possible to determine which carbons are close to, but not connected to, which protons. 
Signal is based on system of nJCH where N>1. 
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Figure 33. Molecule of Qt-salt of mercaptopyridine PDI (31) where all carbon atoms 
corresponding to 1H NMR signals are numbered. Numbering is given to aid 
interpretation.  
From proton signal (1H) integral values it was possible to determine that structure corre-
sponds to molecule with this amount of protons. Signal shows smaller doublets around 
aromatic part of proton signal. This was interpreted that sample contains both 1,6- and 
1,7-isomers. 
NMR 1H signal can be observed in Figure 34 below. This spectrum is interpreted using 
2D NMR spectra from Figure 35, Figure 36 and Figure 37 in Table 1 below. Here Carbon-
proton pair number refers to numbered carbons in Figure 33. Chemical shift corresponds 
to signals of 1H spectrum in Figure 34. Rounded integral number corresponds to number 
of protons for observed chemical shift, signal type is the signal multiplicity and J-values 
are the spin-spin coupling values for multiplet signals, and they are from the same afore-
mentioned spectrum. 
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Figure 34. 1H NMR spectrum of Qt-Salt of dimercaptopyridine PDI (31) in D2O. 
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Figure 35. COSY NMR spectrum of Qt-Salt of dimercaptopyridine PDI (31) in D2O. 
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Figure 36. HMBC NMR spectrum of Qt-Salt of dimercaptopyridine PDI (31) in D2O. 
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Figure 37. HSQC NMR spectrum of Qt-Salt of dimercaptopyridine PDI (31) in D2O. 
 
Table 1. 1H NMR-spectrum interpretation of Qt-salt of dimercaptopyridine PDI (31). 
Carbon-proton 
pair number 
Chemical 
shift 1H 
(ppm) 
Normalized inte-
gral (number of 
H) 
Signal 
type 
J-value 
(Hz) 
Coupled to 
(from COSY) 
1 3.31 18 singlet - - 
2 4.04 6 singlet - - 
3 3.72 4 triplet 7.02 4 
4 4.63 4 triplet 5.27 3 
5 8.25 4 doublet 7.02 6 
6 7.52 4 doublet 6.44 5 
7 ? 8.42 2 doublet 8.19 8 
8 ? 8.70 2 doublet 8.19 7 
9 8.60 2 singlet - - 
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COSY spectrum gave further confirmation on the selected numbering. After COSY only 
uncertainty left was the order of carbon-proton pairs 7 and 8. Unfortunately the resolution 
of gHSQC and gHMBC spectra did not give definite answer to this question. 
Carbon-Proton pairs of signals that were determined from gHSQC and gHMBC are pre-
sented in Table 2 below.  
Table 2. Signal pairs from gHSQC and gHMBC NMR experiments. Paired proton and 
carbon shifts are given and sign is given for gHSQC signals. 
Signal pairs  
HSQC  
proton carbon pos/neg  
2.67 34.32 +  
3.31 53.42 +  
3.71 62.07 -  
4.04 47.16 +  
4.61 33.24 -  
7.5 124.17 +  
8.3 203.77 + uncertain 
    
HMBC   
proton carbon   
3.31 53.4   
3.31 62.1   
4.04 144   
3.31 185 uncertain  
 
To get more information on expected 1H NMR spectra the molecule was modeled using 
computational method. Software used was PerkinElmer ChemBioDraw, Level: Ultra, 
Version: 13.0.0.3015.  
Molecule was modeled using built in feature that calculates 1H NMR spectra in CDCl3 
and in DMSO-d6. However, the NMR spectroscopy was done using D2O as solvent and 
therefore these models were only be used as general guides. This modeling gave identical 
results for both solvents except for the signal coming from CH group number 8. This 
signal was shifted from 8.06 to 8.12 when modeling with CDCl3 and DMSO-d6 respec-
tively. This modeling provided reasonable guidelines for what kind of shifts and signals 
to expect. 
Computational model would suggest, that proton signal in CH number 8 is more shifted 
than in CH number 7. 
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3.3 Results from first synthetic plan 
Several attempts were made on first synthetic plan. However, the mono-pyrrolidine sub-
stitution of PDI was not achieved and problems aroused in subsequent purification of the 
compound. Several attempts were made but they proved unsuccessful. Second step would 
have been the addition of 9H-carbazole to the other side of perylene molecule. To cir-
cumvent this issue, mono 9H-carbazole substitution was tried before pyrrolidine substi-
tution, but even this approach did not produce monosubstituted molecule with any decent 
yield. 
First reactions were performed using pyrrolidine as substituent. 
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Figure 38. First attempt to follow the first synthesis plan. Target molecule was 1-
Bromo,7-pyrrolidine PDI. 
Product was purified using CC. Stationary phase was silica 60 and eluent CHCl3:EtOH 
9:1. However, this combination proved to be cumbersome and following purification at-
tempts were performed using silica 100 and CHCl3:EtOH:Et3N 93:6,5:0,5. This modifi-
cation improved the moving and separation of different components. After purification 
the collected components were tested using MS (ESI-TOF). Major product was discov-
ered to contain mainly dipyrrolidine PDI. Results can be observed in below Figure 39. 
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Figure 39. MS (ESI-TOF) Results after first pyrrolidine reaction. Target molecule is 
observed at around 680 m/z. 
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This pyrrolidine substitution reaction was repeated using temperature of 0°C and reaction 
time of around 4 hours. While the product can be observed in MS (ESI-TOF), the NMR 
results were inconclusive. This was possibly due to extremely low amount of product.  
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Figure 40. Second attempt on pyrrolidine monosubstitution. 
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Figure 41. MS (ESI-TOF) results from second attempt on monopyrrolidine substitution. 
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Figure 42. First attempt on mono9H-carbazole substitution. 
Mono 9H-carbazole substitution was attempted following the previous pyrrolidine reac-
tions. Reaction was completed and CC was performed on product. 3 separate bands were 
collected, but no MS (ESI-TOF) results were obtained. This was due to extremely low 
amount of collected products and defective measurement equipment. 
Second attempt was performed using scheme from below Figure 43. Same scheme was 
performed 4 times in total using different equalities. Equalities for 9H-carbazole were 
measured against component 20 and ranged from 0.65 to 3. All other components were 
equalized accordingly following procedure from literature. [56] 
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Figure 43. Second attempt on mono 9H-carbazole substitution. 
However all of these attempts failed. Later it was discovered that K2CO3 was not com-
pletely dry. Unfortunately no additional attempts could be performed due to lack of time. 
46 
3.4 Following work 
This dye was created as a candidate for ROS production. Subsequent actions should aim 
for proving the antimicrobial abilities of this dye. This could be performed simply by 
dissolving small amount of dye to water and applying this colored water to filter paper. 
This should create sufficient matrix for the dye. Although leeching will be an issue, this 
setup should provide comparable results in efficacy of this dye. In addition this test setup 
could be applied to verify the dark toxicity of this perylene diimide dye against selected 
bacteria. Furthermore its singlet oxygen generating ability should be tested. 
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4. EXPERIMENTAL 
All commercially available solvents and reagents were purchased from Sigma-Aldrich or 
from VWR (Merck KGaA) and were used without further purification unless otherwise 
mentioned. All reactions were done using magnetic stirring unless stated otherwise. Re-
action vessels were 40 ml clear glass vials made by VWR with screw necks. [57] Purifi-
cation of products was performed by column chromatography or by preparative thin layer 
chromatography (TLC) plates. In CC the column was prepared using silica 100 (Merck) 
with pore size 0.063-0.200 mm. TLC plates were coated with aluminum oxide 60 F254 
(Merck). Water refers to purified Milli-Q® water. 
High-resolution mass spectra were recorded using Waters LTC Premier XE ESI-TOF 
bench top mass spectrometer. Leucine enkephaline (LEU-ENK) was used as reference 
compound in acquisition of mass. Nuclear magnetic resonance spectra were recorded us-
ing a 300 MHZ Varian Mercury spectrometer using TMS as internal standard. Absorption 
spectra were measured using Shimadzu UV-2510PC UV-Vis Recording spectrometer. 
Glass filters were produced by Duran and their nominal pore sizes are in the Table 3 
below. [58] 
Table 3. Porosity table.  Porosity number in left column and nominal pore size in right 
column. 
Porosity Nominal max. pore size (μm) 
0  160-250 
1 100-160 
2 40-100 
3 16-40 
4 10-16 
5 1.0-1.6 
48 
4.1 Synthesis 
Synthesis of 5,12-dibromoisochromeno[4',5',6':6,5,10]anthra[2,1,9-def]iso-
chromene-1,3,8,10-tetrone (18) 
Synthesis was done accordimg to the procedure from literature. [59] A total of 0.9992 g 
(1.311 mmol) of PTCDA was dissolved in 8.3 ml of concentrated H2SO4 and solution 
was stirred in RT for approximately 24 hours to dissolve PTCDA. 0.0358 g (0.077 mmol) 
of I2 was added and after 20 minutes 0.15 ml (2.919 mmol) of Br2 was added. Reaction 
was heated to 90 °C for approximately 24 hours while stirring. Excess bromine was let 
out of reaction vessel by air flow. Water was added to reaction vessel to precipitate prod-
uct. Product was first washed with 86 % H2SO4 solution and then with water until the pH 
of waste water reached neutral level. Washing of product was done in №4 filter with 
applied suction. Product was placed in to vacuum desiccator to remove water. 
Synthesis of 5,12-dibromo-2,9-bis[2-(dimethylamino)ethyl]isoquino-
lino[4',5',6':6,5,10]anthra[2,1,9-def]isoquinoline-1,3,8,10(2H,9H)-tetrone (19) 
Synthesis was done following a procedure mentioned in the literature. [60] A total of 
0.4117 g (0.748 mmol) of dibromo PTCDA was dissolved in mixture of 4.3 ml of dioxane 
and 6.3 ml of dimethylformamide (DMF) under Ar-atmosphere in RT while stirring. 0.18 
ml (1.672 mmol) of N,N-dimethylethane-1,2-diamine was added under Ar-atmosphere 
and heating was starter. Reaction was heated to 90-100 °C for 2 hours while stirring. 
Mixture was cooled to RT and water was added to precipitate the product. Product was 
filtered on filtered on №4 filter and washed with water several times. Product was purified 
with column chromatography using around 50 ml of silica 100 with CHCl3:EtOH:Et3N 
(93:6.5:0.5) as eluent. Product was red solid 0.3425 g with 66% yield. Dibromo PDI 1H 
NMR (300 MHz,CDCl3)  ppm 2.31 - 2.40 (m, 13 H) 2.64 - 2.73 (m, 4 H) 4.30 - 4.41 (m, 
4 H) 8.57 - 8.65 (m, 2 H) 8.81 - 8.87 (m, 2 H) 9.38 (d, J=8.19 Hz, 2 H). ESI-TOF (ES+, 
in CHCl3/MeOH 10:15) m/z calcd. for C32H27Br2N4O4 [M+H] 691.0381, found 691.0353. 
Synthesis of 2,9-bis[2-(dimethylamino)ethyl]-5,12-bis(pyridin-4-ylsulfanyl)isoquin-
olino[4',5',6':6,5,10]anthra[2,1,9-def]isoquinoline-1,3,8,10(2H,9H)-tetrone (20) 
A total of 0.0498 g, (0.072 mmol) of compound 2 was placed in a 40 ml vial under Ar-
atmosphere in RT. 0.0246 g (0.178 mmol) of dry K2CO3 was added to vial. As solvent 
4.1 ml of 1-Methylpyrrolidin-2-one (NMP) was added to vial. Then 0.0243 g (0.219 
mmol) of Pyridine-4-thiol was added and vial was placed under cooling. Reaction was 
cooled between -10 °C and -5 °C and kept there for 3 hours. Reaction was stopped by 
adding water. Product was dissolved in CHCl3 and washed with water several times. Ex-
cess solvent was removed and product was purified by aluminum oxide plates using 
CHCl3:EtOH (100:1) as eluent giving 0.0394 g, 72.8 % of violet solid as yield. Dimer-
captopyridine PDI 1H NMR (300 MHz, CHLOROFORM-d)  ppm 2.36 (s, 12 H) 2.70 
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(t, J=6.73 Hz, 4 H) 4.34 (t, J=6.73 Hz, 4 H) 7.05 - 7.20 (m, 4 H) 8.48 (dd, J=4.39, 1.46 
Hz, 4 H) 8.64 - 8.78 (m, 4 H) 8.86 (d, J=8.19 Hz, 2 H). ESI-TOF (ES+, in CHCl3/MeOH 
10:15) m/z calcd. for C42H34N6O4S2 [M] 751.2161, found 751.2141. Abs λmax (ε, M-1cm-
1 in H2O) 533 (16019). 
Synthesis of 4,4'-({1,3,8,10-tetraoxo-2,9-bis[2-(trimethylammonio)ethyl]-
1,2,3,8,9,10-hexahydroisoquinolino[4',5',6':6,5,10]anthra[2,1,9-def]isoquinoline-
5,12-diyl}disulfanediyl)bis(1-methylpyridinium) tetraiodide (21) 
A total of 0.0153 g (0.027 mmol) of compound 3 was added in to vial. Then 0.5 ml (8.032 
mmol) of MeI was added to vial with 3.0 ml of DMF acting as solvent. Vial was kept in 
RT and stirring for around 16 hours. After this product was precipitated and washed with 
diethyl ether several times to remove excess MeI and DMF. Product was dark red/violet 
solid 0.0264 g, 74.2 % yield. QtSalt of dimercaptopyridine PDI 1H NMR (300 MHz, 
DEUTERIUM OXIDE)  ppm  3.31 (s, 18 H) 3.67 - 3.78 (m, 4 H) 4.04 (s, 6 H) 4.58 - 
4.67 (m, 4 H) 7.52 (d, J=6.44 Hz, 4 H) 8.25 (d, J=7.02 Hz, 4 H) 8.42 (d, J=8.19 Hz, 2H)   
8.60 (s, 2 H) 8.69 (d, J=8.19 Hz, 2 H). ESI-TOF (ES+, in CH3CN/H2O 4:1) m/z calcd. 
for C46H46N6O4S2 [M-4I]
4+ 202.5755, found 202.5741; calcd. for C46H46N6O4S2 
[M+Me]3+ 270.1007, found 270.0973;calcd. for C46H46IN6O4S2 [M-3I]
3+ 312.4022, found 
312.4009; calcd. for C46H46I2N6O4S2 [M-2I]
2+ 532.0556, found 532.0536. Abs λmax (ε, M-
1cm-1 in H2O) 530 (24344) 
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5. CONCLUSIONS 
Novel perylene diimide dye was synthesized and characterized by NMR, MS and UV-
Vis. spectral data confirmed the supposed structure.  
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Figure 44. Structure of novel perylene derivative dye. Dye is in cationic form. 
Synthetic scheme is presented in 45 below. 
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Figure 45. Synthetic scheme for perylene diimide derivate dye. 
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